Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

23.42
Delayed Data
As of Jun 24
 -1.47 / -5.91%
Today’s Change
17.92
Today|||52-Week Range
77.73
-22.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues85.4M80.9M124.4M418.3M
 
 
 
 
 
Cost of Goods Sold10.0M10.8M13.3M20.5M
 
 
 
 
 
Depreciation And Amortization3.1M1.2M7.0M69.1M
 
 
 
 
 
 
Operating ExpensesGross Income72.3M68.9M104.1M328.7M
 
 
 
 
 
General Expenses84.8M76.0M97.1M197.9M
 
 
 
 
 
Research And Development33.3M20.6M24.2M42.9M
 
 
 
 
 
Total Operating Expenses97.9M88.0M117.4M287.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-7.1M7.0M130.9M
 
 
 
 
 
Extraordinary Credit0.00--681.0K0.00
 
 
Extraordinary Charge-4.9M-4.5M-11.5M-32.5M
 
 
 
 
 
Interest Expense On Debt0.00--14.7M60.0M
 
 
 
Other Expenses-1.5M964.0K217.0K1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.6M-9.6M-17.3M39.8M
 
 
 
 
 
Income Taxes-854.0K0.00-153.2M-7.1M
 
 
 
 
Net Income-16.8M-9.6M135.8M32.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.4M21.7M22.4M31.5M
 
 
 
 
 
Shares To Calculate EPS Diluted21.4M21.7M25.2M35.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.44$5.45$0.93
 
 
 
 
 
EPS Diluted-$0.78-$0.44$5.38$0.93